Skip to main content
Top

CNS Drugs

Issue 2/2021

Content (7 Articles)

Open Access Parkinson's Disease Current Opinion

24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations

Sandeep Thakkar, Victor S. C. Fung, Aristide Merola, Meredith Rollins, Michael J. Soileau, Norbert Kovács

Neuropathic Pain Therapy in Practice

Pharmacotherapy to Manage Central Post-Stroke Pain

Hanwool Ryan Choi, Adem Aktas, Michael M. Bottros

Stevens-Johnson Syndrome Systematic Review

Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis

Israa Alfares, Muhammad Shahid Javaid, Zhibin Chen, Alison Anderson, Ana Antonic-Baker, Patrick Kwan

Eating Disorder Systematic Review

Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features

Mikail Nourredine, Lucie Jurek, Bernard Angerville, Yannick Longuet, Julia de Ternay, Alain Derveaux, Benjamin Rolland

Open Access Parkinson's Disease Review Article

Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience

Vanessa Raeder, Iro Boura, Valentina Leta, Peter Jenner, Heinz Reichmann, Claudia Trenkwalder, Lisa Klingelhoefer, K. Ray Chaudhuri

Dabigatran Original Research Article

Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients

Senta Frol, Lana Podnar Sernec, Liam Korošec Hudnik, Mišo Šabovič, Janja Pretnar Oblak